GNA11andN-RASmutations: alternatives for MAPK pathway activating GNAQ mutations in primary melanocytic tumours of the central nervous system

GNAQ and GNA11 mutations in melanocytomas of the central nervous system

(2012) Rajmohan Murali et al.   ACTA NEUROPATHOLOGICA

Melanocytic tumor with GNA11 p.Q209L mutation mimicking a foramen magnum meningioma

(2012) Russell G. Strom et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

Therapeutic Implications of the Emerging Molecular Biology of Uveal Melanoma

(2011) M. Patel et al.   CLINICAL CANCER RESEARCH

KIT mutations in ocular melanoma: frequency and anatomic distribution

(2011) Michelle L Wallander et al.   MODERN PATHOLOGY

Evolving concepts in melanoma classification and their relevance to multidisciplinary melanoma patient care

(2011) Richard A. Scolyer et al.   Molecular Oncology

Targeting the RAS pathway in melanoma

(2011) Zhenyu Ji et al.   TRENDS IN MOLECULAR MEDICINE

A Pyrosequencing-Based Assay for the Rapid Detection of IDH1 Mutations in Clinical Samples

(2010) Prashanth Setty et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Mutations inGNA11in Uveal Melanoma

(2010) Catherine D. Van Raamsdonk et al.   NEW ENGLAND JOURNAL OF MEDICINE

Activating mutations of the GNAQ gene: a frequent event in primary melanocytic neoplasms of the central nervous system

(2009) Heidi V. N. Küsters-Vandevelde et al.   ACTA NEUROPATHOLOGICA

Mutational Profile of GNAQQ209 in Human Tumors

(2009) Simona Lamba et al.   PLoS One

KIT Gene Mutations and Copy Number in Melanoma Subtypes

(2008) C. Beadling et al.   CLINICAL CANCER RESEARCH

Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi

(2008) Catherine D. Van Raamsdonk et al.   NATURE